Ocular implant made by a double extrusion process
US10076526B2 · kind B2 · utility
3Cited by
129References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 23, 2015 |
| Grant date | Sep 18, 2018 |
| Priority date | — |
| Expiry date | Nov 23, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/204
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides biodegradable implants sized for implantation in an ocular region and methods for treating medical conditions of the eye. The implants are formed from a mixture of hydrophilic end and hydrophobic end PLGA, and deliver active agents into an ocular region without a high burst release.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.